Announcement on the FDA Approval for Clinical Trial of DC50292A Tablets by Wholly-owned Sub-subsidiary Beijing Double-Crane Runchuang Technology Co., Ltd.
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment